Menu Search
Charts
From 02/05/2022 our Markets Data content will no longer be free to read. To continue to get full access, subscribe now and receive 25% off.
Learn moreSubscribe now
Equities

Extrawell Pharmaceutical Holdings Ltd

858:HKG.HZ

Extrawell Pharmaceutical Holdings Ltd

Actions
  • Price (HKD)0.051
  • Today's Change0.001 / 2.00%
  • Shares traded270.00k
  • 1 Year change+24.39%
  • Beta--
Data delayed at least 15 minutes, as of Nov 04 2024.
More ▼
Find More Stocks
Find More Stocks
Use our equities screener to discover other potential opportunities.
 
Equities ScreenerGo to the Equities Screener

Profile data is unavailable for this security.

About the company

Extrawell Pharmaceutical Holdings Ltd is an investment holding company principally engaged in the development, manufacture and sale of pharmaceuticals. The Company operates its business through three segments. The Manufacturing segment is engaged in the development, manufacture and sales of pharmaceutical products. Its self-produced products include Transfer Factor Oral Solution, Wisk, ZhouBang and others. The Trading segment is engaged in the promotion and distribution of imported pharmaceuticals. Its imported products include Millibar and Skin Cap. The Gene Development segment is engaged in the commercial development and research, development of gene-related technologies.

  • Revenue in HKD (TTM)59.10m
  • Net income in HKD-162.95m
  • Incorporated1998
  • Employees159.00
  • Location
    Extrawell Pharmaceutical Holdings LtdSuites 2206-08, 22nd Floor, Devon House,Taikoo Place, 979 King's Road,Quarry Bay Hong KongHKG
  • Phone+852 28561918
  • Fax+852 28563139
  • Websitehttp://www.extrawell.com.hk
More ▼
Data Provided by LSEG
All markets data located on FT.com is subject to the FT Terms & Conditions
All content on FT.com is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by FT and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.
Any information that you receive via FT.com is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. FT is not responsible for any use of content by you outside its scope as stated in the FT Terms & Conditions.